Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Liraglutide and dulaglutide have demonstrated similar glycemic efficacy and safety. However, they differ in treatment administration and injection devices. The purpose of this study was to examine and compare patient perceptions of the injection devices used with liraglutide and dulaglutide.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Curr Med Res Opin

Title: Current medical research and opinion

Publisher: Informa UK Limited

ISSN (Electronic): 1473-4877

ISSN (Print): 0300-7995

Publication date (Electronic): Aug 2018

Volume: 34

Issue: 8

Affiliations

[1 ] a Patient-Centered Research, Evidera , Bethesda , MD , USA.

[2 ] b Eli Lilly and Company , Indianapolis , IN , USA.

Article

DOI: 10.1080/03007995.2018.1465903

PubMed ID: 29661026

SO-VID: eb4bf47a-127c-49f1-adf0-7ebec7c8dc76

History

Keywords: Injection device,diabetes injection device experience questionnaire,diabetes injection device preference questionnaire,dulaglutide,liraglutide,type 2 diabetes

Data availability:

Keywords: Injection device, diabetes injection device experience questionnaire, diabetes injection device preference questionnaire, dulaglutide, liraglutide, type 2 diabetes

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.

Read this article at

Abstract

Related collections

Scientific Phone Apps and Mobile Devices

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 594

Cited by 16